CABAZITAXEL DR.REDDY'S cabazitaxel 60 mg/1.5 mL concentrated injection vial
देश: ऑस्ट्रेलिया
भाषा: अंग्रेज़ी
स्रोत: Department of Health (Therapeutic Goods Administration)
सार्वजनिक आकलन रिपोर्ट
(PAR)
16-05-2019
अनुरोध भेजा।
सक्रिय संघटक:
cabazitaxel, Quantity: 60 mg
थमां उपलब्ध:
Dr Reddys Laboratories Australia Pty Ltd
फार्मास्यूटिकल फॉर्म:
Injection, concentrated
रचना:
Excipient Ingredients: polysorbate 80; citric acid
प्रशासन का मार्ग:
Intravenous Infusion
पैकेज में यूनिट:
1
प्रिस्क्रिप्शन प्रकार:
(S4) Prescription Only Medicine
चिकित्सीय संकेत:
Cabazitaxel Dr.Reddy?s in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.
उत्पाद समीक्षा:
Visual Identification: Clear yellow to brownish-yellow viscous solution.; Container Type: Multiple containers; Container Material: Glass; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
प्राधिकरण का दर्जा:
Registered
प्राधिकरण की तारीख:
2018-07-23
